Prometheus Biosciences, Inc., (RXDX): Price and Financial Metrics

Prometheus Biosciences, Inc., (RXDX): $199.92

0.18 (+0.09%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add RXDX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked


in industry

RXDX Price/Volume Stats

Current price $199.92 52-week high $199.98
Prev. close $199.74 52-week low $23.27
Day low $199.60 Volume 1,860,600
Day high $199.98 Avg. volume 913,102
50-day MA $184.19 Dividend yield N/A
200-day MA $109.60 Market Cap 9.56B

RXDX Stock Price Chart Interactive Chart >


Prometheus Biosciences, Inc., (RXDX) Company Bio


Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of precision therapeutics and companion diagnostics products for the treatment and diagnosis of inflammatory bowel diseases (IBD). Its products include PRA023, a Phase I clinical trial IgG1 humanized monoclonal antibody (mAb); PR600, an anti- tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1800, anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. The company has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. Prometheus Biosciences, Inc. was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. The company was founded in 2016 and is based in San Diego, California.


RXDX Latest News Stream


Event/Time News Detail
Loading, please wait...

RXDX Latest Social Stream


Loading social stream, please wait...

View Full RXDX Social Stream

Latest RXDX News From Around the Web

Below are the latest news stories about PROMETHEUS BIOSCIENCES INC that investors may wish to consider to help them evaluate RXDX as an investment opportunity.

Top Healthcare Stocks for June 2023

Top healthcare stocks include Theravance Biopharma for best value, Dr Reddy's Laboratories for fastest growth, and Viking Therapeutics for most momentum.

Yahoo | June 8, 2023

Top Small-Cap Stocks for June 2023

Biggest movers include Prometheus, TG Therapeutics, and Akero Therapeutics, all more than quadrupling in price in the last year while the Russell 2000 Index stays nearly unchanged.

Yahoo | June 6, 2023

3 Innovative Growth Stocks to Buy for Next-Gen Profits

These are the innovative growth stocks for future profits and these stocks are poised for multibagger returns.

Faisal Humayun on InvestorPlace | May 31, 2023

Is Bristol Myers Squibb a Top Dividend Stock?

Its hefty yield isn't the only reason to consider buying this top pharma stock.

Yahoo | May 31, 2023

3 Undervalued Pharma Stocks to Buy for High Total Returns

These are the undervalued pharma stocks to buy for high total returns as these companies are poised for steady growth and cash flow upside.

Faisal Humayun on InvestorPlace | May 19, 2023

Read More 'RXDX' Stories Here

RXDX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 75.35%
3-year 669.22%
5-year N/A
YTD N/A
2023 0.00%
2022 178.20%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!